Davis Polk & Wardwell and Zhong Lun Law Firm advised Chinese biopharmaceutical company Antengene Corporation on its $335 million IPO in Hong Kong, with Herbert Smith Freehills and Commerce & Finance Law Offices advising the joint sponsors and the underwriters.
S&R Associates has represented India’s Embassy REIT on its $1.3 billion acquisition of Embassy TechVillage assets from affiliates of sponsors Embassy Group, which were advised by Khaitan & Co.
Thailand’s Chandler MHM has advised Phu Yen TTP Joint Stock Company (Phu Yen JSC) on a $186 million loan to develop and operate a 257MW solar power plant in Hoa Hoi, Phu Yen Province, Vietnam, with Clifford Chance representing the lenders.
Shearman & Sterling, Fangda Partners and Tian Yuan Law Firm have advised Chinese cancer cell therapy developer JW Therapeutics on its $300 million IPO in Hong Kong, with Davis Polk & Wardwell and Commerce & Finance Law Offices counselling the joint sponsors and underwriters.
Skadden, Arps, Slate, Meagher & Flom, Tian Yuan Law Firm and Conyers have advised China’s New Oriental Education & Technology on its HK$10.13 billion ($1.31 billion) secondary offering on the Hong Kong Stock Exchange, with Herbert Smith Freehills and Jia Yuan Law Offices counselling the joint sponsors and underwriters.
Allen & Gledhill, TMI Associates, Haiwen & Partners and YKVN have advised Nanofilm Technologies International on its S$510.1 million ($383.53 million) initial public offering on the Singapore Exchange Securities Trading (SGX-ST), with Allen & Overy and JunHe counselling the issue managers and bookrunners.
O'Melveny & Myers, Tian Yuan Law Firm and William Ji & Co. have represented China’s Simcere Pharmaceutical Group on its HK$3.57 billion ($460.6 million) Hong Kong IPO, with Herbert Smith Freehills and Jingtian & Gongcheng advising the joint sponsors.